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In Vivo Linking of Membrane 
Lipids and the Anion Transporter 
Band 3 with Thiourea-modified 
Amphiphilic Lipid Probes
Akihiro Moriyama, Naohiro Katagiri, Shinichi Nishimura, Nobuaki Takahashi & 
Hideaki Kakeya
Membrane proteins interact with membrane lipids for their structural stability and proper function. 
However, lipid–protein interactions are poorly understood at a molecular level especially in the 
live cell membrane, due to current limitations in methodology. Here, we report that amphiphilic 
lipid probes can be used to link membrane lipids and membrane proteins in vivo. Cholesterol and a 
phospholipid were both conjugated to a fluorescent tag through a linker containing thiourea. In the 
erythrocyte, the cholesterol probe fluorescently tagged the anion transporter band 3 via thiourea. 
Tagging by the cholesterol probe, but not by the phospholipid probe, was competitive with an 
anion transporter inhibitor, implying the presence of a specific binding pocket for cholesterol in 
this ~100 kDa protein. This method could prove an effective strategy for analyzing lipid–protein 
interactions in vivo in the live cell membrane.
How membrane lipids and membrane proteins interact with each other is a fundamental question in 
biology, as lipid–protein (LP) interactions are expected to play important roles in the cell membrane1–3. 
Biochemical analyses have unveiled specific functions of membrane lipids; for example, conferring ther-
mal stability to proteins and modulating the affinity between proteins and ligands. However, membrane 
lipids can regulate protein properties either directly by binding to a specific pocket, or indirectly by 
changing the physical properties of the membrane surrounding the protein, such as the curvature, lateral 
pressure, and bilayer thickness. So far, several dozen membrane proteins have been found to interact 
with membrane lipids through the analysis of X-ray crystal structures4. Recently, ion-mobility mass spec-
trometry was used to screen for lipids that specifically bind to membrane proteins and thereby increase 
structural stability5. However, we have to carefully interpret data regarding the physiological role of the 
LP interactions detected in vitro, whereas confirming these membrane lipid interactions with proteins in 
the live cell membrane remains technically challenging.
For linking small molecule ligands and their cellular receptors, chemical strategies utilizing various 
reactive groups have been employed6–10. Active site–directed irreversible inhibitors have been used to 
label target proteins7, and are sometimes used to tag shared mechanistic and structural features of large 
enzyme classes; for example, fluorophosphonates can tag serine hydrolase family proteins8,9. On the other 
hand, the decoration of high-affinity ligands with reactive functions enables labeling of the receptor 
molecule in the proximity of the active site. The quantity, activity, and subcellular localization of the 
corresponding protein can therefore be detected using these approaches. Theoretically, such irreversible–
modification approaches may be applicable to membrane lipids for detecting LP interactions. So far, a 
couple of photoreactive lipid probes have been utilized for global analysis of in vivo LP interactions11–13. 
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However, the potential of lipid probes possessing reactive groups other than photoreactive functions has 
not been explored. Here we demonstrate that the chemical tagging approach using thiourea as a reactive 
function can indeed be used to link lipids and the anion transporter band 3 in the erythrocyte mem-
brane. This approach enabled us to identify a putative binding pocket of cholesterol in a large ~100 kDa 
membrane protein.
Results
Chemical tagging of band 3 by a cholesterol probe. Cholesterol (1), the key lipid species in reg-
ulating the membrane order14, likely modulates protein stability and function in general15. There have 
been reports of cholesteryl ethers with polyethylene glycol (PEG) forming liposomes16 or micelles17,18 
in aqueous solutions. Such amphiphilic molecules can be used as cholesterol probes with no membrane 
permeability, e.g. fluorescein-labeled PEG-cholesterol molecules with a PEG repeat of 50 or 200 were 
shown to distribute to cholesterol-rich domains in the outer leaflet of the plasma membrane18,19. We 
designed and synthesized a cholesterol probe (2) and surveyed the interactions of cholesterol in the sheep 
erythrocyte (Fig. 1). The cholesterol probe 2 has a short linker for chemically tagging amino acids near 
the cholesterol binding site. We chose thiourea as the reactive moiety because of its mild reactivity. As 
expected, the fluorescence of probe 2 was observed mainly on the cell surface, when erythrocytes were 
treated with the probe (Fig.  2a). The treated erythrocytes were lysed and subjected to SDS-PAGE, fol-
lowed by fluorescence imaging. We detected tagging of a ~100 kDa protein with high specificity (Fig. 2b). 
In contrast, the control probe 3, in which cholesterol was replaced with a Boc group, neither bound to the 
cells nor tagged the protein (Fig. 2a,b). Judging from the molecular weight and the SDS-PAGE pattern, 
the tagged protein was identified as the anion transporter band 3, which was subsequently confirmed by 
LC-MS/MS analysis (Figure S1).
Band 3 is the most abundant protein in the erythrocyte membrane (30% in human erythrocytes)20. 
No other protein bands tagged by the cholesterol probe 2 were detectable. The tagging level saturated 
after 24 h incubation in the presence of 400 nM of probe 2, and a linear correlation between the tagging 
level and the probe concentration was observed below 800 nM using an 8 h incubation period (Figure 
S2). The tagging level was tentatively estimated to be 0.073% when incubated with 400 nM of probe 2 
for 8 h (Figure S2). This low-level tagging was likely due to mild-reactivity of thiourea (see Fig. 3). The 
abundance of endogenous cholesterol in the erythrocyte membrane can also contribute to the low effi-
ciency; the quantity of cholesterol in human erythrocytes is 36 nmol/10 e8 cells21, whereas 0.4 nmol of 
probe 2 was incubated with 10 e8 cells in our experiments. Significant competition would therefore have 
been present between the abundant endogenous cholesterol and the cholesterol probe. In addition, there 
is a possibility that probe 2 can access band 3 in a specific conformation only, or in a specific complex; 
band 3 is known to exist in at least three populations, including the ankyrin-associated complex, the 
Figure 1. Chemical structures of lipids and lipid probes. 
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junctional complex, and as free dimers22,23, and within each class are subpopulations with further struc-
tural heterogeneity24.
Reactivity of thiourea with amine. To our knowledge, thiourea has never previously been utilized 
for cross-linking biological molecules. The involvement of thiourea was investigated by synthesizing 
another cholesterol probe 4 in which an amide group was used to conjugate fluorescein to the linker. 
Probe 4 bound to the erythrocytes to a level comparable to that of probe 2 (Fig. 2c). However, no tag-
ging of band 3 was detected, thus confirming the reactivity of thiourea in the cell membrane (Fig. 2d). 
We next synthesized a model compound and analyzed the reactivity of thiourea under aqueous condi-
tions. When we mixed the model molecule 5 with an excess amount of n-propylamine, the amount of 5 
gradually decreased to give rise to a new peak (6) observed by LC-MS analysis (Fig. 3). We purified the 
newly-emerged compound 6 and analyzed its structure by MS and NMR spectra. The ion peak in ESI 
MS revealed the molecular formula of C41H46N4O9, which lacked the S atom and had additional C3H7N 
compared with 5 (m/z 739.3334 [M + H]+, Δ mmu = 0.4, calcd for C41H47N4O9). In addition, the 13C 
NMR spectrum of compound 6 did not show a quaternary carbon signal (δC 182.5 ppm) corresponding 
to the thiourea carbon in compound 5. Instead, a new carbon signal (δC 156.4 ppm) and a set of signals 
corresponding to the propyl group were detected. These data indicated that thiourea and n-propylamine 
reacted to yield guanidine (Fig.  3), which was supported by the fully assigned 1H NMR data. Because 
the reactivity of thiourea was low, the specific tagging by probe 2 led us to hypothesize that cholesterol 
binds with high affinity to band 3.
Biophysical analyses had predicted the strong binding of cholesterol to band 3, an interaction that 
may regulate the structure and transporter activity of this protein25–27. So far however, nothing has been 
reported regarding the location of the binding pocket. To investigate the tagging site of the choles-
terol probe 2, a competitive tagging assay using 4,4′-diisothiocyanostilbene-2,2′ -disulfonic acid (DIDS), 
an anion transporter inhibitor, was examined. When erythrocytes were treated with DIDS, we found 
that tagging by cholesterol probe 2 was significantly suppressed (85% inhibition after 24 h incubation) 
(Fig.  4a). DIDS is known to form covalent bonds with two lysine residues, e.g. Lys 539 and Lys851 in 
human band 3, although Lys851 is only reactive at high pH (> 8)28. In sheep erythrocytes, Lys539 is 
conserved (Lys557 in sheep), whereas Lys851 is replaced by Arg869, suggesting that Lys557 reacted with 
thiourea in the cholesterol probe 2 (Fig.  5, S1). Alternatively, tagging by cholesterol probe 2 may be 
Figure 2. Tagging of the anion transporter band 3 by the cholesterol probe 2. (a,b) Binding and tagging 
with the cholesterol probe 2. Erythrocytes were treated with probe 2 or 3 (400 nM) at 37 °C, and observed 
under fluorescence microscopy (a). Bright field (DIC) and fluorescent images are shown. Scale bar, 5 μ m. 
After 8 h incubation, cells were lysed and analyzed by SDS-PAGE (b). The fluorescence and CBB images of 
the gel are shown. Asterisk indicates band 3. (c,d) Erythrocytes were treated with the cholesterol probe 2 or 
4, and analyzed as in (a,b).
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inhibited allosterically by DIDS. In fact, band 3 is expected to be fixed in an outward conformation by 
stilbene compounds such as DIDS29, which likely inhibit anion transport activity in an allosteric man-
ner30. It is noted that cysteine, another nucleophilic amino acid residue, was not necessary for tagging 
band 3 since pretreatment of erythrocytes with excess amount of N-ethylmaleimide did not inhibit it 
(Figure S3).
Ligand-dependent tagging of band 3. We finally expanded our approach to another membrane 
lipid, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) (7). We designed probe 8 with the 
same structural features as that of the cholesterol probe 2. The DPPE probe 8 bound to erythrocytes to a 
similar level as cholesterol probes 2 and 4 (Figure S4). Interestingly, probe 8 also specifically tagged band 
3 (Fig. 4b, S4). The kinetics of the tagging was similar to that of the cholesterol probe 2 (Figure S4), while 
the tagging efficiency was slightly higher than that of probe 2 (0.21% vs 0.073%) (Figure S2). However, 
in this case, the competitive effect of DIDS was minor (11.3% inhibition at 24 h; Fig. 4b). This suggested 
that the binding site of the DPPE probe 8 is not overlapped with the DIDS binding site, or not affected by 
the conformational change of band 3 by DIDS (Fig. 5). Otherwise, there might be multiple hydrophobic 
pockets for probe 8, and the overall tagging level was not decreased upon binding of DIDS. Although 
we can only speculate the binding mode of the DPPE probe 8, it is clear that band 3 has multiple lipid 
binding sites that were occupied by lipid probes 2 and 8. The atomic basis of these interactions would be 
more precisely analyzed by X-ray crystal structure analysis.
Discussion
The approach presented here to link lipids and proteins in the cell membrane has several unique fea-
tures. First, the lipid probes we used are amphiphilic. Amphiphilicity can suppress membrane permea-
bility, which is a key point when considering the specific tagging of membrane molecules. In fact, when 
the lipid probes were treated with the erythrocyte lysate, proteins other than band 3 were also tagged 
(Figure  S5). This indicates that the reactivity of thiourea was regulated by the amphiphilicity of the 
probe, which would enable the introduction of other reactive groups to optimize the tagging rate and 
the modes of tagging. Next, we applied a novel chemical tagging strategy to the endogenous membrane 
molecules. Pioneering studies have shown that membrane proteins can be efficiently tagged by chem-
ical probes, which are designed based on soluble inhibitors31,32. In contrast, our results demonstrated 
that we could analyze the interactions between endogenous lipids and membrane proteins, in spite of 
the highly competitive environment in vivo. The interactions between cholesterol and membrane pro-
teins are expected to be stabilized by three interactions: hydrophobic interactions, hydrogen bonding 
interactions, and CH-π interactions33,34. Although the cholesterol probe 2 cannot form hydrogen bond-
ing due to the absence of the free hydroxyl group at C-3, the hydrophobic and CH-π interactions by 
cholest-5-en structure in probe 2 could mimic the interaction between cholesterol and proteins. Finally, 
the thiourea-containing lipid probes revealed a tentative binding site for cholesterol in band 3 (Fig. 5). 
Although we can speculate that there are multiple interactions between cholesterol and band 3, our cho-
lesterol probes tagged a specific binding site. This might be due to the limited reactivity of thiourea; tag-
ging by thiourea requires the presence of specific amino acids, i.e., lysine, located in the close proximity 
to the lipid probe. In contrast, cholesterol probes possessing photoreactive diazirine allowed researchers 
to identify several hundred cholesterol-binding proteins using proteomic analyses12. The combination of 
Figure 3. Reactivity of thiourea with amine. (a) Time course analysis of the reaction converting 
compound 5 to 6. Compound 5 was incubated with n-propylamine (3473 eq) and analyzed by LC-MS. UV 
chromatograms at 488 nm are shown. (b) Chemical structures of model compounds 5 and 6. The thiourea 
compound 5 was converted to the guanidine compound 6 in the presence of excess n-propylamine.
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narrowly-reactive probes for analyzing specific interactions with highly-reactive probes for comprehen-
sive analysis would have significant advantages for LP interactome analyses35.
In summary, we have demonstrated that the chemical tagging strategy is feasible for analyzing LP 
interactions in the cell membrane. Amphiphilic lipid probes can be used to analyze a specific LP interac-
tion, and this may prove applicable to comprehensive proteomic analyses by tuning the probe reactivities. 
Expanding this approach to exogenous molecules targeting membrane lipids, such as antibiotics, is also 
an attractive challenge.
Methods
General considerations for organic synthesis. All reagents and solvent were used as received 
from commercial suppliers and were used without further purification. IR spectra were measured using 
an FTIR spectrometer equipped with a ZnSe ATR plate. Optical rotations were determined using the 
sodium D line (589 nm). NMR spectra were measured on a 500 MHz instrument. 1H and 13C chemical 
shifts (δ ) are shown in parts per million (ppm), and coupling constants (J) are in hertz (Hz). The fol-
lowing abbreviations are used to describe multiplicities: s, singlet; d, doublet; t, triplet; dd, doublet of 
doublets; dt, doublet of triplets; tt, triplet of triplets; m, multiplet; br, broad; ovl, overlapped. Mass spec-
tral data were collected with ESI IT-TOF MS. Flash column chromatography was performed over Silica 
Flash F60 (SiliCycle) using an elution system as described for each experiment. Synthesis procedures and 
physico-chemical properties are described in the Supplementary Information file.
General materials and methods for Biochemical/Biological Experiments. Sheep whole blood 
was purchased from Kohjin Bio Co., Ltd. and used within two weeks after blood collection. Fluorescent 
images of SDS-PAGE gels were acquired with Typhoon 9400 (GE Healthcare). Fluorescent images of cells 
were acquired using an Olympus IX81 microscope equipped with UPLSAPO 100× objective (Olympus, 
Tokyo, Japan).
Tagging of anion transporter band 3 with probes. Sheep whole blood (0.5 mL) was centrifuged 
(300 g × 5 min, unless stated) and supernatant was discarded. The precipitated red blood cells (RBC) 
were washed with 0.7 mL of ice-cold phosphate buffer (10 mM phosphate, 150 mM NaCl, pH 7.4) for 
5 times, and re-suspended in 0.5 mL of phosphate buffer. RBC suspensions (1 mL, 108 cells/mL) were 
mixed with lipid probes (0.4 μ M, 0.4% DMF), and incubated at 37 °C for 8 h with continuous mixing. 
Microscope analysis was performed within 30–60 min after addition of probes. After incubation, RBC 
suspensions were centrifuged, washed with 1 mL of ice-cold phosphate buffer twice, and mixed with 
Figure 4. Competitive tagging of band 3 by lipid probes. Erythrocytes were pre-treated with a transporter 
inhibitor DIDS (100 μ M) for 30 min, then time-dependent tagging was examined using the cholesterol probe 
2 (a) or the DPPE probe 8 (b). The concentration of the probes was 400 nM. The fluorescence intensities 
relative to that obtained after 24 h incubation in the absence of DIDS are shown. The tagging level in 
the absence (black solid line, Figures S2 and S4) or in the presence (red dashed line) of DIDS is shown. 
Means ± SD of 3–6 experiments are shown.
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80 μ L of SDS-PAGE sample buffer. After boiling at 100 °C for 5 min, 20 μ L of the sample was subjected to 
SDS-PAGE (8%) and the fluorescent images were acquired (Ex: 488 nm; Em 532 nm.). All proteins were 
stained by CBB and the signal intensity was calculated using MetaMorph software (Molecular Devices).
Competition assay with DIDS. Washed RBC solutions (× 108 cells/mL) were prepared as described. 
RBCs were treated with DIDS (final concentration: 100 μ M in 0.4% DMF) on ice for 30 min in the dark. 
After incubation, RBC solution was centrifuged, and washed with phosphate buffer (1 mL) twice fol-
lowed by washing with a BSA solution (0.5 w/v% BSA in PBS). After extensive PBS wash of RBCs (1 mL 
each, three times), RBCs were suspended in 1 mL of phosphate buffer and treated with lipid probes as 
described above.
Reactivity test of the thiourea-containing model compound 5. Compound 5 (2 mg/mL, 2.8 mM) 
was mixed with n-propylamine (400 μ L, 3473 eq), 4,4′ -bis(2-methyl-2-propanyl)biphenyl (0.4 mg/mL), 
DMF (50 μ L), and water (50 μ L), which was stirred at 37 °C. After incubation, the reaction mixture 
(10 μ L) was mixed with 200 μ L of water, lyophilized, and dissolved in 500 μ L of DMF. A portion (1 μ L) 
of the prepared sample was subjected to LC-MS analysis. The analytes were separated by an ODS column 
(Senshu-PAK PEGASIL ODS SP100, φ3 × 100 mm, 30 °C) using a gradient elution system (50–100% aq 
MeOH, 200 μ L/min).
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